Close Menu
Skip to main content
GenomeWeb
360Dx
Precision Oncology News
Precision Oncology News
*
*
Show password
Forgot your password?
Subscribe
Contains all of these words:
You may find more results for this query on our sister sites:
GenomeWeb
and
360Dx
.
Business & Policy
Business News
Regulatory News
Reimbursement
Biomarkers
BRCA
EGFR
HER2
KRAS
BRAF
ROS1
ALK
PD-L1
Cancer Specialties
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Ovarian Cancer
Brain Cancer
Melanoma
Pediatric Cancer
Oncology Trends
Next-Generation Sequencing
Minimal Residual Disease
Microsatellite Instability Testing
Immunotherapy
Liquid Biopsy
Resources
Webinars
White Papers
Conferences & Events
Menu
Home
›
About Us
›
Our Staff
›
Miriam Munn
Miriam Munn
Premium Content Account Manager
Phone Number
+1-212-651-5612
Email
[email protected]
Breaking
News
Phase I Study of Novel Drug Shows Preliminary Activity in Mesothelin-Expressing Tumors
ImaginAb, AstraZeneca Enter License Agreement for CD8 ImmunoPET Technology
Myriad Genetics Seeks Japan Approval for Advanced Pancreatic, Prostate Cancer Companion Diagnostic
CStone Submits Ayvakit for Approval in Taiwan for PDGFRA Exon 18-Mutated Stomach Cancer
Pfizer's Ibrance, Jiangsu Alphamab's KNO26 Advancing in HER2-Positive Breast Cancer Study
Tolero Pharmaceuticals Drug Added to Beat AML Umbrella Trial
